Competitive Inhibition by Danazol of Progesterone and Dihydrotestosterone Binding to Human Uterine Progestin and Androgen Receptors
Danazol competitively inhibited the binding of progesterone and dihydrotestosterone to human uterine progestin and androgen receptors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Full text
521 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Placebo-controlled comparison of danazol and high-dose medroxypro-gesterone acetate in the treatment of endometriosis after conservative surgery 1987
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro 1986
- Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors 1987
- Medical treatment of mild endometriosis associated with infertility 1991
Cited by (4)
- Medical treatment of mild endometriosis associated with infertility 1991
- Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors 1987
- Placebo-controlled comparison of danazol and high-dose medroxypro-gesterone acetate in the treatment of endometriosis after conservative surgery 1987
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro 1986
Source provenance
- openalex
- last seen: 2026-05-10T10:30:22.895345+00:00